Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis

Caution is warranted to detect the aggravation of portal hypertension when administering Atez/Bev to young patients or patients with an impaired liver function or pretreatment spleen enlargement. The impact of spleen modulation by Atez/Bev appears to be limited on clinical efficacy.

Authors

Institutions

Publication Details

Journal
Oncology
Published
2024-08-20
DOI
https://doi.org/10.1159/000541002
Citations
4
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
1.48
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis

Hideko Ohama, Joji Tani, Tomomitsu Matono, Kazuhito Kawata et al.
4 citations
Oncology
Hepatocellular Carcinoma Treatment and Prognosis
1.48
article

Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis

Hideko Ohama, Joji Tani, Tomomitsu Matono, Kazuhito Kawata, Kazuya Kariyama, Hidenori Toyoda, Kazuhiro Nouso, Takeshi Hatanaka, Atsushi Hiraoka, Takashi Kumada, Takuya Nagano, Ei Itobayashi, Toshifumi Tada, Atsushi Naganuma, Akemi Tsutsui, Toru Ishikawa, Satoru Kakizaki, Yutaka Yata, Fujimasa Tada, Asahiro Morishita, Koichi Takaguchi, Naoto Saito, Shinichiro Nakamura
article en
4 citations

Abstract

Caution is warranted to detect the aggravation of portal hypertension when administering Atez/Bev to young patients or patients with an impaired liver function or pretreatment spleen enlargement. The impact of spleen modulation by Atez/Bev appears to be limited on clinical efficacy.

OncologyVol. 103(2)
Gunma University (JP), Kagawa University (JP), Hamamatsu University School of Medicine (JP), Saiseikai Niigata Daini Hospital (JP), National Hospital Organization Takasaki Medical Center (JP), Okayama Prefecture (JP), Ogaki Municipal Hospital (JP), Himeji Medical Center (JP), Hanwa Memorial Hospital (JP), Gunma Saiseikai Maebashi Hospital (JP), Himeji Red Cross Hospital (JP), Asahi General Hospital (JP), Ehime Prefectural Central Hospital (JP), Kagawa Prefectural Central Hospital (JP), Takarazuka City Hospital (JP), Gifu Kyoritsu University (JP)
Good health and well-being
Openalex Percentile: Top 18%
Hepatocellular Carcinoma Treatment and Prognosis
1.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.